Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before, potentially resulting in a 15% CAGR in FreeStyle Libre sales by 2028. With Abbott acquiring rights to 4 more biosimilar products and a double-digit CAGR in the target biosimilar emerging markets, the EPD business could stimulate EPS growth beyond Medical Devices. With an excellent balance sheet and over 50 consecutive years of dividend increases, Abbott is a robust long-term investment for income investors.
Enterprise Products (EPD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
I share the keys I insist on when identifying income investments. I share my top income investment today. I also share some honorable mentions.
![]() 0S23 5 months ago | Other | $0.54 Per Share |
![]() 0S23 8 months ago | Other | $0.53 Per Share |
![]() 0S23 11 months ago | Other | $0.53 Per Share |
![]() 0S23 29 Apr 2024 | Other | $0.52 Per Share |
![]() 0S23 30 Jan 2024 | Other | $0.52 Per Share |
29 Jul 2025 (In 3 weeks) Date | | 0.62 Cons. EPS | - EPS |
28 Jul 2025 (In 3 weeks) Date | | - Cons. EPS | - EPS |
28 Apr 2025 Date | | - Cons. EPS | - EPS |
30 Jan 2025 Date | | - Cons. EPS | 0.74 EPS |
29 Oct 2024 Date | | - Cons. EPS | 0.65 EPS |
![]() 0S23 5 months ago | Other | $0.54 Per Share |
![]() 0S23 8 months ago | Other | $0.53 Per Share |
![]() 0S23 11 months ago | Other | $0.53 Per Share |
![]() 0S23 29 Apr 2024 | Other | $0.52 Per Share |
![]() 0S23 30 Jan 2024 | Other | $0.52 Per Share |
29 Jul 2025 (In 3 weeks) Date | | 0.62 Cons. EPS | - EPS |
28 Jul 2025 (In 3 weeks) Date | | - Cons. EPS | - EPS |
28 Apr 2025 Date | | - Cons. EPS | - EPS |
30 Jan 2025 Date | | - Cons. EPS | 0.74 EPS |
29 Oct 2024 Date | | - Cons. EPS | 0.65 EPS |
Oil & Gas Midstream Industry | Energy Sector | A. James Teague CEO | LSE Exchange | US2937921078 ISIN |
US Country | 7,300 Employees | 31 Jan 2025 Last Dividend | 22 Aug 2014 Last Split | 28 Jul 1998 IPO Date |
Enterprise Products Partners L.P. is an established provider of midstream energy services, catering to both producers and consumers across a variety of sectors including natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. With operations spanning four key segments – NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services – the company boasts a comprehensive infrastucture designed to support the energy industry's complex supply chain needs. Founded in 1968 and operating out of Houston, Texas, Enterprise Products Partners L.P. plays a critical role in the transportation, storage, and processing of energy commodities across the United States.